| RS2148119483 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS2148120604 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS2148120607 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148120627 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148120711 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148121838 |
FLNA
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia, Periventricular nodular heterotopia |
| RS2148121859 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148121877 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS2148121907 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2148121932 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2148126338 |
CHM
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2148126410 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148126425 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148126477 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148127827 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148127941 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128122 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128139 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128153 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128199 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148128297 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128349 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148128390 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148128459 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128483 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128554 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, Nonpapillary renal cell carcinoma |
| RS2148128715 |
EMD
|
Health Risk |
Likely pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128756 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128811 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128862 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128871 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128932 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128957 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148128961 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2148131600 |
HDAC8
|
Health Risk |
Pathogenic |
— |
| RS2148131678 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2148132672 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS2148135255 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Childhood hypophosphatasia |
| RS2148135377 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2148138686 |
RBFOX2
|
Health Risk |
Likely pathogenic |
RBFOX2-related congenital heart disorder, RBFOX2-related congenital heart disorder |
| RS2148140779 |
RPL10
|
Health Risk |
Likely pathogenic |
— |
| RS2148141994 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148143198 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148143831 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2148143998 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Thyroid cancer |
| RS2148144372 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148144488 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2148149936 |
SLC9A6
|
Health Risk |
Likely pathogenic |
— |
| RS2148150789 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148150795 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2148151094 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2148151806 |
KCNT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 57 |
| RS2148152217 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148152270 |
KDM6A
|
Health Risk |
Likely pathogenic |
— |
| RS2148152364 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148152544 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, ALPL-related disorder |
| RS2148152665 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2148152698 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148153507 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148153518 |
CHM
|
Health Risk |
Conflicting classifications of pathogenicity |
Choroideremia, Choroideremia |
| RS2148153587 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Choroideremia, Choroideremia |
| RS2148154145 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148154378 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148156504 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148156632 |
SLC9A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148158064 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148158307 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2148158314 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult hypophosphatasia, Hypophosphatasia |
| RS2148158612 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148158695 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148159628 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148161378 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148161624 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148161800 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148162290 |
AMMECR1
|
Health Risk |
Likely pathogenic |
— |
| RS2148163144 |
RSPO1
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome, Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome |
| RS2148163693 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2148165155 |
ALG13
|
Health Risk |
Likely pathogenic |
— |
| RS2148165214 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2148166435 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148166660 |
ALK
|
Health Risk |
Likely pathogenic |
Lung cancer, Lung cancer |
| RS2148166991 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148167494 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148168763 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148169033 |
CHM
|
Health Risk |
Pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2148169289 |
KDM6A
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2148169594 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2148169894 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148171286 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Childhood hypophosphatasia |
| RS2148171627 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148172518 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148173968 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Thyroid cancer |
| RS2148174022 |
SLC9A6
|
Health Risk |
Likely pathogenic |
— |
| RS2148179162 |
SLC9A6
|
Health Risk |
Likely pathogenic |
— |
| RS2148179292 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2148179919 |
STAG2
|
Health Risk |
Pathogenic |
— |
| RS2148183488 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148183552 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148183611 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148183751 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |